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Abstract 
Kabuki syndrome (KS, OMIM 147920) also known as Niikawa-Kuroki syndrome, is a 
multiple congenital anomaly/mental retardation syndrome characterized by a distinct facial 
appearance. The cause of KS has been unidentified even by whole genome scan with array 
comparative genomic hybridization (CGH). In recent years, high resolution oligonucleotide 
array technologies enable us to detect fine copy number alterations. In 17 patients with KS, 
molecular karyotyping was performed with GeneChip 250K NspI array (Affymetrix) and 
CNAG (Copy Number Analyser for GeneChip). It revealed seven copy number alterations, 
three deleted region and four duplicated region, among the patients with the exception of 
registered copy number variants (CNVs). Among the seven loci, only the region of 
9q21.11-q21.12 (~1.27 Mb) involved coding genes, i.e., TRPM3, KLF9, SMC5 and MAMDC2. 
Mutation screening for the genes detected 10 base substitutions consisting of seven single 
nucleotide polymorphisms (SNPs) and three silent mutations in 41 patients with KS. Our 
study could not reveal causative genes for KS, but the locus of 9q21.11-q21.12 in association 
with cleft palate may contribute to its manifestation of KS in the patient. Since various 
platforms on oligonucleotide arrays have been developed, higher resolution platforms will 
need to be applied to search tiny genomic rearrangements in patients with KS. 
 
Key words: Kabuki syndrome/Microdeletion/Molecular karyotyping/Mutation 
screening/Niikawa-Kuroki syndrome 
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Introduction 
Kabuki syndrome (KS, OMIM 147920) also known as Niikawa-Kuroki syndrome, is a 
multiple congenital anomaly/mental retardation (MCA/MR) syndrome characterized by a 
distinct facial appearance, skeletal abnormalities, joint hypermobility; dermatoglyphic 
abnormalities, postnatal growth retardation, recurrent otitis media and occasional visceral 
anomalies.
1,2
 The prevalence was estimated to be 1/32,000 in Japan
3
 and 1/86,000 in Australia 
and New Zealand.
4
 Although most cases were sporadic, at least 14 familial cases have been 
reported. It is thought that KS is an autosomal dominant disorder considering the equal 
male-to-female ratio of patients and parent-child transmission pattern in some familial cases.
5
 
The cause of KS remains unknown, even though at least 400 patients have been 
known in a variety of ethnic groups since 1981.
3-7
 Some works have ruled out several loci, 
e.g., 1q32-q41, 8p22-p23.1 and 22q11, from the candidate for KS.
8-13
 A study of array-based 
comparative genomic hybridization (CGH) showed a disruption of C20orf133(MACROD2) 
gene by ~250 kb deletion on a patient with KS
14
, but the following mutation screening for the 
gene failed to find pathogenic base change within exons in other 19 patients with KS
14
 and in 
43 Japanese patients.
15
 Another study of array CGH with 0.5 – 1.2 Mb resolution reported that 
2q37 deletions were detected in two patients with Kabuki-like features but their facial feature 
were not typical for KS.
16
 To date, no concordant specific lesion have been found by whole 




Chromosomal aberration analysis by high resolution oligonucleotide array 
technologies in recent years, called molecular karyotyping, enable us to detect 
submicroscopic pathogenic copy number alterations which were undetectable by even BAC 
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array CGH.
19,20
 Since not a few MCA/MR syndromes are due to chromosomal copy number 
aberration, we hypothesize that some sort of microdeletion/microduplication cause KS. 
Herein we report the results of molecular karyotyping in 17 patients with GeneChip 250K 
array and mutation screening of candidate genes in 41 patients with KS in Japan. 
 
Materials and methods 
Subjects 
The subjects for molecular karyotyping consisted of 18 patients (nine girls and nine 
boys) at entry. The subjects for mutation screening consisted of 41 patients (20 girls and 21 
boys) including aforementioned 18 patients. The diagnoses of KS were confirmed by experts 
of clinical genetics, though written permission for the use of facial photographs in 
publications was not obtained. These Japanese patients showed normal karyotype at 400 band 
level, who were previously reported with no pathogenic genome copy number change by 1.5 
Mb-resolution BAC array CGH.
18
 Genomic DNA was isolated by the standard method from 
their peripheral blood leukocytes or in part from their lymphoblastoid cell lines. Experimental 
procedures were approved by the Committee for the Ethical Issues on Human Genome and 
Gene Analysis in Nagasaki University. 
 
Molecular karyotyping 
DNA oligomicroarray hybridization using the GeneChip® Human Mapping 250K 
Nsp Array (Affymetrix, Santa Clara, CA, USA) was performed for 18 patients with KS 
following the provided protocol (Affymetrix). Data were analyzed to detect copy number 
aberration using GTYPE (GeneChip Genotyping Analysis Software) and visualized with 
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CNAG (Copy Number Analyser for GeneChip) ver.3.
21
 References for non-paired analysis of 
CNAG were chosen from eight unrelated individuals of HapMap samples from Affymetrix 
website (http://www.affymetrix.com/support/). The resolution of this procedure was estimated 
as ~30 – 100 kb. CNAG ver.3 was linked with the University of California Santa Cruz 
(UCSC) genome browser (http://genome.ucsc.edu/) assembly May 2004, and then its physical 
position was referred to the data assembly on March 2006 in the UCSC genome browser after 
adjustment. 
 
Validation of deletion 
Quantitative polymerase chain reaction (qPCR) analysis to validate deletions was run 
on a LightCycler 480 Real-Time PCR System (Roche Diagnostics, Mannheim, Germany) 
using an intercalating dye, SYTO9 (Molecular probes, OR, USA), which is an alternative to 
SYBR green I.
22
 Absolute quantification with second derivative max method was used for 
quantification. A standard curve of amplification efficiency for each set of primers was 
generated with a serial dilution of genomic DNA. A corrected gene dosage was given as a 
ratio of a target gene divided by an internal control gene. The copy number was obtained from 
a calibration under the assumption that the control genome was diploid. 
Target genes of copy number aberration were as follows: SUMF1 (for patient K9); 
MAMDC2 (for patient K16); CETN1 (for patient K34). The primer sequences of these genes 
are available in online supplementary file. Internal control diploid genes were OAZ2 and 
USP21. Primer sets of the control genes for genomic DNA were selected from Real Time 
PCR Primer Sets website (http://www.realtimeprimers.org/). The control genes were 
confirmed to have no copy number variants on Database of Genomic Variants (DGV) updated 
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on June 26, 2008 (http://projects.tcag.ca/variation/). BLAST searches confirmed all primer 
sequences specific for the gene. 
Samples were analyzed in triplicate in 384 well format in a 10 l final volume 
containing about 2 ng of genomic DNA, 0.5 M forward primer, 0.5 M reverse primer, 0.1 
Units TaKaRa ExTaq HS version (TaKaRa, Kyoto, Japan), 1x PCR buffer, 200 M dNTP, and 
0.5 M SYTO9. The amplification conditions consisted of first denaturation at 95°C for 5 min, 
followed by 45 cycles of denaturation at 95°C for 10 sec, annealing at 55°C for 10 sec, and 
extension at 72°C for 15 sec. Data was analyzed with using LightCycler 480 Basic Software 
(Roche Diagnostics) and melting curve was checked to eliminate nonspecific products from 
the reaction. 
 
Mutation screening of candidate genes 
Candidate genes, identified within a detected deletion, consisted of four genes: 
TRPM3 (NM_001007471 and NM_206946), KLF9 (NM_001206), SMC5 (NM_015110), and 
MAMDC2 (NM_153267) located at 9q21.12-q21.11. The entire coding region and splice 
junctions of the genes were sequenced on an automated sequencer 3130xl (Applied 
Biosystems, Foster City, CA, USA) using BigDye ver.3.1 (Applied Biosystems). Genomic 
sequences were retrieved from the UCSC genome browser (assembly: Mar, 2006). PCR 
primers were designed with the assistance of Primer3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi). The primer sequences are available in 
online supplementary file. Resultant electropherograms were aligned using ATGC v3.0 
(Software Development, Tokyo, Japan) and inspected visually to find DNA alterations. 
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In silico analysis 
Relations among deleted genes were assessed with online software PANTHER 
(Protein Analysis Through Evolutionary Relationships, http://www.pantherdb.org) to 
determine whether the genes involve some developmental pathway or biological process.
23
 
Novel synonymous base substitutions found in the mutation screening were examined for 
their potential activation of cryptic splice site by comparison between wild type allele and 




Molecular karyotyping and Validation of deletion 
The entries of molecular karyotyping were 18 patients with KS (K1, K3, K5, K6, K7, 
K8, K9, K11, K12, K13, K16, K18, K20, K21, K22, K23, K34, and K38). We eliminated the 
data of patient K3 from copy number analysis, because it showed low quality data, i.e. single 
nucleotide polymorphism (SNP) call rate 82.51% and quality control performance detection 
rate 74.09%, probably due to DNA degradation during the long term storage. The other 
patients showed high call rates enough for copy number analysis (SNP call rate, 
90.07%-97.72% and detection rate, 91.52%-99.77%). We identified nine deleted regions, 
which lengths were between ~35 kb and ~1.27 Mb, and nine duplicated regions, its length 
between ~72 and ~495 kb, in the 17 patients analyzed (Table 1). As for detected nine 
duplications, five of them were concordant to several observed gains in DGV and four of 
them in each patient did not contain any known genes. 
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Interestingly, the deleted region of 9q21.11-q21.12 (~1.27 Mb in patient K16), which 
had not been registered in DGV, harbored four known genes: TRPM3, KLF9, SMC5 and 
MAMDC2 (Figure 1d). The deletion of 3p26.2 (~205 kb in patient K9, Figure 1a) had 
involved in a noncoding exon of SUMF1gene. The deletion of 18p11.32 (~35 kb in patient 
K34, Figure 1b) containing CETN1 gene had one registration in DGV as Variation_5044, 
which described only one observed loss and 14 observed gain of 95 individuals. The deletion 
of 4q13.2 (~1.26 Mb in patient K23, Figure 1c) and 20p12.1 (~152 kb in patient K6) did not 
carry any coding exon of any gene. The regions of 14q11.2 (~116 kb in patient K5) and 
15q11.2 (~972 kb in patient K1 and K23) were non-pathologic deletions with the many 
registrations as observed losses in DGV. 
To validate the deletion of the detected region, we confirmed its loss of 
heterozygosities of SNP probes there with GTYPE (data not shown) and performed qPCR. 
The regions of SUMF1 on 3p26.2 (for patient K9) and MAMDC2 on 9q21.11-q21.12 (for 
patient K16) had one copy in each patient compared with unaffected individuals (Figure 2). 
The deletion of CETN1 on 18p11.32 (for patient K34) was inherited from his unaffected 
mother. Because the parents’ samples of the patient K16 were unavailable, it was unable to 
examine whether the deletion of 9q21 was de novo or not. But the deletion was not found in 
95 normal Japanese individuals by qPCR (data not shown).  
In consequence of this copy number analysis, we considered the next four genes as 
candidate genes for KS: TRPM3 (Transient receptor potential cation channel, subfamily M, 
member 3), KLF9 (Kruppel-like factor 9), SMC5 (Structural maintenance of chromosomes 
protein 5) and MAMDC2 (MAM domain containing 2). 
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Mutation screening and in silico analysis 
Table 2 shows the results from mutation screening of the four candidate genes in 41 
patients with KS. Ten base substitutions were found in the 41 patients, consisting of six 
registered SNPs, one unregistered SNPs and three silent mutations. In addition, SUMF1 
(NM_182760) and CETN1 (NM_004066) were also screened but no mutations were detected 
(data not shown). 
We checked the three silent mutations for splice site alteration using GeneSplicer 
program, but no activation of cryptic splice site was predicted. While PANTHER 
classification of the four candidate genes did not show significant correlation for biological 
processes or pathway because of its small scale in number, some genes associated with 
developmental biology, i.e. DNA repair (SMC5) and mRNA transcription regulation (KLF9).  
 
Discussion 
We used high resolution oligonucleotide array of GeneChip 250K NspI with the 
resolution of 30 - 100 kb setting and tried to find causative deletions or mutated genes for KS. 
Our molecular analysis did not show the causative gene for KS with strong evidence, but we 
identified a locus possibly contributed to KS. 
The deletion in patient K16, its length ~1.27 Mb in size at 9q21.11 - q21.12, harbored 
four known gene: TRPM3, KLF9, SMC5 and MAMDC2 (Figure 1d). Unfortunately her 
parents’ DNAs were unavailable, but the region is unlikely copy number variant (CNV) 
because it has not been known as CNV in DGV and additionally the deletion was not found in 
95 normal Japanese individuals by qPCR. 
Since mutation screening in 41 patients with KS revealed no pathogenic base 
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substitution in these genes, we cannot state that these genes are major genetic factors for KS. 
However, it is presumable that the genes have some etiological roles for KS because of its 
genetic heterogeneity. Ontology of PANTHER classification suggested the three genes were 
associated with developmental biology, such as mRNA transcription regulation. Moreover, the 
1.27 Mb region of 9q21 was included in previously reported candidate locus of cleft lip/palate 
by meta-analysis of linkage analysis.
24
 The patient K16 actually had velopharyngeal 
insufficiency due to the submucous cleft palate. Therefore, it is reasonable to consider the 
deleted genes cooperated with development of a cleft palate, which is often accompanied by 
KS. 
Although the ~152 kb deletion within intron 5 of C20orf133 (MACROD2) in patient 
K6 did not involve any coding exon and her parents’ DNAs were unavailable, the deletion 
was neither registered as CNV in DGV nor found in 95 normal Japanese individuals by qPCR 
(data not shown). Maas et al
14
 reported de novo ~250 kb deletion including exon 5 of 
C20orf133 (MACROD2) in a patient with KS. Direct sequencing for the gene in other 62 
patients with KS did not detect mutations
14,15
, but the gene may be one of the causative genes 
for KS in consideration of its genetic heterogeneity. 
We focused this study for KS on deletion/duplication detected by oligonucleotide 
array and mutation screening of the coding genes within the region. One limitation of the 
study is its resolution. As a matter of course, higher resolution array can detect smaller 
genomic rearrangements which were undetectable in a same patient, as we showed here 
compared with previous study of BAC array CGH.
18
 While SNP probes are useful to examine 
loss of heterozygosity as a collateral evidence in deletions, unevenly-distributed probes of the 
SNP array have disadvantage for CNV detection. Since various platforms on oligonucleotide 
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array have developed, higher resolution platforms will need to be applied to search tiny 
genomic rearrangements in patients with KS. Another limitation is that we assumed a single 
copy number change caused KS. It remains to be elucidated that whether CNV association
25
 
contribute to manifestations of KS. If the further investigation with refined array technologies 
could not find the etiology of KS, the direction of study for KS will have to be changed to 
find de novo sequence alteration or methylation aberration including even in the noncoding 
genomic regions. 
In summary, we applied molecular karyotyping with GeneChip 250K array to detect 
copy number aberrations in 17 patients with KS and screened the four candidate genes in 41 
patients with KS. We could not identify causative DNA alteration for KS, but the locus, 
9q21.11-q21.12 including TRPM3, KLF9, SMC5 and MAMDC2, may contribute to the cleft 
palate of KS. Further investigations will be needed since various array platforms have the 
potential to specify genomic alterations for KS. 
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Titles and legends to figures 
 
Figure 1  Chromosome view of CNAG analysis. 
Each dots represent fluorescent intensity on each SNP probe of GeneChip 250K NspI array 
(Affymetrix). Solid lines indicate copy number analyzed with CNAG. Arrows show detected 
deletions. 
(a) Chromosome 3 of patient K9, ~205 kb deletion in 3p26.2 involving an exon of 
SUMF1gene. 
(b) Chromosome 18 of patient K34, ~35 kb deletion in 18p11.32, containing CETN1 gene. 
(c) Chromosome 4 of patient K23, ~1.26 Mb deletion in 4q13.2, not involving any known 
gene. 
(d) Chromosome 9 of patient K16, ~1.27 Mb deletion in 9q21.11-q21.12, harboring four 
genes: TRPM3, KLF9, SMC5 and MAMDC2. The UCSC genome browser denotes the 
cytobands, genes, and probe setting of Affymetrix 250K NspI array within the region. No 
copy number variation was registered here in Database of Genomic Variants updated June 26, 
2008. 
 
Figure 2  Validation of deletion with quantitative PCR. 
Quantitative PCR confirmed a loss of one copy in each patient: SUMF1 at 3p26.2 for patient 
K9; MAMDC2 at 9q21.1 for patient K16; CETN1 at 18p11.32 for patient K34. The deletion of 






3p26.3 K7 1 460 kb 1435279 1895554 N.R. Variation_8235
3p26.2 K9 1
a 205 kb 4009368 4214847 SUMF1 Variation_8973, 8975, 30169
4q13.2 K23 1
a 1.26 Mb 66329014 67591611 N.R. N.R.
5q21.2-q21.3 K22 1 281 kb 104301325 104581898 N.R. Variation_3568
9q21.11-q21.12 K16 1
a 1.27 Mb 71760296 73031176 TRPM3, KLF9, SMC5, MAMDC2 N.R.
14q11.2 K5 1 166 kb 19336854 19502641 OR4N2, OR4K2, OR4K5, OR4K1
Variation_0376, 7028, 8094,
9234, 9235




a 35 kb 545074 580003 CETN1 Variation_5044
20p12.1 K6 1
a 152 kb 14993412 15145890 C20orf133 (MACROD2)
b N.R.
4q12 K5 3 104 kb 54251599 54355281 N.R. N.R.
8q11.21 K7 3 171 kb 50641101 50812548 N.R.
Variation_2751, 3731, 8601,
37765
10p15.2-p15.1 K5 3 142 kb 3663600 3805292 N.R. N.R.
13q31.1 K6 3 72 kb 82451568 82523728 N.R. N.R.
15q11.2 K7, K9, K12 3 877 kb 19112164 19989036 CXADRP2, POTEB
Variation_3070, 3951, 8784,
30670, etc.
15q25.1 K9 3 165 kb 76992181 77156751 CTSH, RASGRF1 Variation_3970, 7073
16q21 K13 3 283 kb 58508008 58791285 N.R. N.R.
17q12 K7 3 495 kb 31428390 31923810





22q11.22 K5, K12 3 278 kb 20907806 21186081 VPREB1, ZNF280B Variation_5356, 34540
CN, Copy number; DGV, Database of Genomic Variants; N.R., no registeration in UCSC genes or DGV; 
a
 Validated by quantitative PCR.
b
 Deleted region was within intron 5 of the C20orf133 (MACROD2)  and did not involve any coding exon.
15
Physical position
Involving Gene(s) Concordant Loss/Gain on DGV
Table 1.  Detected genomic copy number aberrations in 17 patients with Kabuki syndrome.
Cytoband CN State LengthPatient(s) ID
Homo Hetero
459C>T A153A 0 1 N.R. 0 synonymous
4023G>A S1341S 13 28 rs3739776 ― SNP, synonymous
KLF9 459C>T V153V 0 1 N.R. 0 synonymous
916G>A V306I 37 4 rs1180116 ― SNP, nonsynonymous
922T>C C308R 21 10 rs1180117 ― SNP, nonsynonymous
62T>C L21P 0 2 N.R. 0.02 SNP, nonsynonymous
492C>T T164T 0 1 N.R. 0 synonymous
816C>T Y272Y 11 16 rs2296772 ― SNP, synonymous
867G>A A289A 13 15 rs2296773 ― SNP, synonymous












Results of mutation screening
TRPM3, Transient receptor potential cation channel, subfamily M, member 3; KLF9, Kruppel-like factor 9; SMC5, Structural maintenance
of chromosomes protein 5; MAMDC2, MAM domain containing 2; dbSNP, registration number of database of SNP
(http://www.ncbi.nlm.nih.gov/SNP/)
a
Allele frequency was calculated from 188 chromosomes of 94 individuals.
Table 2  Mutation screening of candidate genes in 41 patients with Kabuki syndrome
TRPM3
SMC5
MAMDC2
Patient(s)
with KS
